Executive Summary
Across the single filing in the USA Trading Suspensions stream, Volato Group, Inc. (SOAR) faces severe NYSE American delisting risk due to stockholders’ equity falling below $2.0M (losses in two of three recent fiscal years) and $4.0M (losses in three of four recent fiscal years), signaling prolonged financial distress with no provided YoY/QoQ recovery trends. Negative sentiment dominates with 9/10 materiality, highlighting non-compliance under Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide. No immediate trading suspension impacts Class A Common Stock (SOAR) on NYSE American, but warrants (SOARW) already trade on OTC Markets, foreshadowing potential further liquidity erosion. Absent enriched data on insider activity shows no management buying conviction, while forward-looking compliance deadlines (plan by April 16, 2026; regain standards by December 17, 2026) create a high-stakes catalyst calendar. Capital allocation details unavailable, but sustained losses imply strained shareholder returns with no dividends or buybacks noted. Portfolio-level theme: isolated small-cap aviation player exemplifies regulatory vulnerability amid equity deficits, urging immediate position reviews.
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from March 20, 2026.
Investment Signals(11)
- Volato Group (SOAR)(BEARISH)▲
Stockholders’ equity below $2.0M threshold due to losses in two of three recent fiscal years, violating Section 1003(a)(i)
- Volato Group (SOAR)(BEARISH)▲
Equity also under $4.0M from losses in three of four recent fiscal years, breaching Section 1003(a)(ii) with multi-year loss trend
- Volato Group (SOAR)(BEARISH)▲
Negative sentiment at 9/10 materiality from March 17, 2026 NYSE notice, no counterbalancing bullish metrics
- Volato Group (SOAR)(BEARISH)▲
No enriched insider trading activity indicating buys or pledges, lacking management conviction amid distress
- Volato Group (SOAR)(BEARISH)▲
Warrants (SOARW) already relegated to OTC Markets trading, signaling early-stage delisting precedent for common stock
- Volato Group (SOAR)(BEARISH)▲
Absence of capital allocation data (dividends, buybacks) amid equity deficits suggests zero shareholder returns prioritization
- Volato Group (SOAR)(BEARISH)▲
No forward-looking guidance on revenue/margins, only regulatory compliance targets highlighting operational weakness
- Volato Group (SOAR)(BEARISH)▲
Recent fiscal years show consistent losses QoY (2/3 and 3/4 periods), with no period-over-period equity improvement trends
- Volato Group (SOAR)(BEARISH)▲
High regulatory halt risk in trading suspensions stream, single-filing outlier with no peers for relative outperformance
- Volato Group (SOAR)(BEARISH)▲
No M&A or transaction details to bolster balance sheet, isolated equity erosion vs. potential sector consolidations
- Volato Group (SOAR)(BEARISH)▲
Operational metrics implied weak (sustained losses), no capacity/volume growth to offset equity compliance failure
Risk Flags(8)
- Volato Group/Delistings↓[HIGH RISK]▼
Must submit compliance plan by April 16, 2026, or face delisting proceedings, with regain deadline December 17, 2026
- Volato Group/Equity Deficiency↓[HIGH RISK]▼
Stockholders’ equity < $2.0M from losses in 2/3 recent FY, direct NYSE non-compliance under 1003(a)(i)
- Volato Group/Loss Trends↓[HIGH RISK]▼
Losses in 3/4 recent fiscal years drove equity < $4.0M, multi-period deterioration with no QoQ recovery
- Volato Group/Trading Impact↓[MEDIUM RISK]▼
Class A (SOAR) at risk of halt post-compliance failure, warrants already OTC-exiled reducing liquidity
- Volato Group/Sentiment↓[HIGH RISK]▼
Uniformly negative analysis (9/10 materiality), no mixed elements or bullish offsets in enriched data
- Volato Group/Insider Silence↓[MEDIUM RISK]▼
Zero reported insider transactions/holdings changes, potential concern signal absent buying support
- Volato Group/Capital Strain↓[HIGH RISK]▼
No dividends/buybacks/splits in enriched data, equity losses imply cash preservation over returns
- Volato Group/No Guidance↓[MEDIUM RISK]▼
Lacking forward revenue/profit forecasts, only regulatory timelines flag execution uncertainty
Opportunities(7)
- Volato Group/Compliance Turnaround↓(OPPORTUNITY)◆
Successful plan submission by April 16, 2026 could extend runway to December 17 compliance, potential short-covering rally
- Volato Group/Short Bias↓(OPPORTUNITY)◆
High delisting probability from sustained losses offers alpha via shorts on SOAR amid no insider support
- Volato Group/OTC Arbitrage↓(OPPORTUNITY)◆
Warrants (SOARW) on OTC may decouple post-delisting; monitor spreads vs. SOAR for relative value plays
- Volato Group/Event Catalyst↓(OPPORTUNITY)◆
April 16 plan filing as near-term binary event, position for volatility if equity recapitalization hinted
- Volato Group/Equity Infusion↓(OPPORTUNITY)◆
Watch for unlisted M&A or capital raise details in plan to close $2-4M equity gap
- Volato Group/Peer Comparison↓(OPPORTUNITY)◆
As sole filing outlier, relative short vs. compliant aviation peers if sector trends emerge
- Volato Group/Liquidity Exit↓(OPPORTUNITY)◆
Proactive selling ahead of December 17 deadline avoids OTC discount, lock in value now
Sector Themes(5)
- Delisting Momentum in Small Caps(BEARISH IMPLICATION)◆
1/1 filings show equity < $2-4M from multi-year losses, implying broad vulnerability for loss-making microcaps
- Regulatory Halts Precedent(WATCH IMPLICATION)◆
NYSE notices without immediate suspensions (SOAR trading intact) set pattern for phased delisting risks
- Equity Erosion Trends(BEARISH IMPLICATION)◆
Losses in 2/3 to 3/4 recent FY aggregate to chronic deficits, no YoY recovery across stream
- OTC Migration Path(BEARISH IMPLICATION)◆
Warrants to OTC signals common stock trajectory, liquidity theme for suspension-prone names
- Catalyst Compression(ACTIONABLE IMPLICATION)◆
Narrow compliance windows (Apr-Dec 2026) highlight time-sensitive regulatory pressures
Watch List(7)
Submit by April 16, 2026; monitor for equity raise or cost-cut details to gauge regain feasibility [Apr 16, 2026]
Full NYSE compliance required by December 17, 2026, or delisting; track equity trends quarterly [Dec 17, 2026]
Post-April 16 hearing risk if plan rejected; watch for halt notices [Post-Apr 16, 2026]
No current trades; monitor Form 4s for CEO/CFO buying/selling signaling conviction [Ongoing]
OTC warrant trading spreads as leading delisting indicator; watch volume decoupling [Ongoing]
Debt-to-Equity implied high from equity lows; await next 10-Q for ROE/margin updates [Next Quarterly Filing]
Loss drivers (volumes/costs) undisclosed; track aviation sector peers for relative distress [Ongoing]
Filing Analyses(1)
23-03-2026
On March 17, 2026, Volato Group, Inc. received a notice from NYSE American LLC indicating non-compliance with continued listing standards under Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide due to stockholders’ equity below $2.0M (for losses in two of three recent fiscal years) and $4.0M (for losses in three of four recent fiscal years). The Company must submit a compliance plan by April 16, 2026, to regain standards by December 17, 2026, or face delisting proceedings, though there is no immediate impact on trading of its Class A Common Stock (SOAR) on NYSE American. Warrants (SOARW) trade on OTC Markets Group, Inc.
- ·Company address: 1954 Airport Road, Suite 124, Chamblee, GA 30341
- ·Telephone: 844-399-8998
- ·SEC Commission File Number: 001-41104
- ·IRS Employer Identification No.: 86-2707040
- ·Emerging growth company status: Yes
Get daily alerts with 11 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 1 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)